K

Knotus Co Ltd
KOSDAQ:278650

Watchlist Manager
Knotus Co Ltd
KOSDAQ:278650
Watchlist
Price: 1 664 KRW 3.55% Market Closed
Market Cap: ₩144.8B

Net Margin

-10.7%
Current
Declining
by 2.8%
vs 3-y average of -7.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-10.7%
=
Net Income
₩-7.6B
/
Revenue
₩71.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-10.7%
=
Net Income
₩-7.6B
/
Revenue
₩71.5B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Knotus Co Ltd
KOSDAQ:278650
140.6B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
160.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.9B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.1B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
Loading...

Market Distribution

Lower than 79% of companies in Korea
Percentile
21th
Based on 2 632 companies
21th percentile
-10.7%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Knotus Co Ltd
Glance View

KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.

Intrinsic Value
2 342.67 KRW
Undervaluation 29%
Intrinsic Value
Price
K
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-10.7%
=
Net Income
₩-7.6B
/
Revenue
₩71.5B
What is Knotus Co Ltd's current Net Margin?

The current Net Margin for Knotus Co Ltd is -10.7%, which is below its 3-year median of -7.9%.

How has Net Margin changed over time?

Over the last 3 years, Knotus Co Ltd’s Net Margin has decreased from 4.6% to -10.7%. During this period, it reached a low of -14.7% on Dec 31, 2024 and a high of 4.6% on Sep 30, 2022.

Back to Top